SOMA is teaming up with Quality Clinical Research (QCR) to bring exciting new opportunities to South Omaha! Come find us during the Cinco de Mayo events this weekend to learn about studies we will be conducting, freebies, and how we can help your family.
Who is QCR?
Quality Clinical Research (QCR) originated here in Omaha , NE in 2003. Since their opening they have hosted several studies in phases 2 through 4. They have highly skilled medical staff that continue in education and training in order to provide the best Quality in healthcare to their patients. QCR is associated with some of Omaha ‘s best physicians. From family physicians to specialist, they have a wide range of knowledge and experience.
Why Clinical Research?
Clinical research evaluations involve studying the safety and effectiveness of new treatments, medications, medical devices, and procedures through carefully designed clinical trials. These trials typically involve human participants and are conducted in several phases to test different aspects of the treatment, including its safety, dosage, efficacy, and side effects.
Clinical research evaluations are crucial because they help identify new treatments and therapies that can improve health outcomes and save lives. By testing these treatments in controlled environments with rigorous scientific methods researchers can determine whether they are safe and effective for use in the general population. This helps to ensure that patients receive the best possible care, while also advancing our understanding of diseases and their underlying mechanisms. Additionally, clinical research evaluations can help to identify potential risks and side effects of treatments, leading to better informed decisions and improved patient safety.
Minority Involvement is critical.
It is important to have minorities in clinical research evaluations because different ethnic and racial groups may respond differently to treatments due to genetic and environmental factors, including differences in lifestyle, culture, and healthcare access. Thus, by including a diverse group of participants in clinical trials, researchers can better understand how different populations may react to treatments and develop more personalized and effective healthcare interventions. This can also help to address healthcare disparities and ensure that new treatments and therapies are accessible and appropriate for everyone, regardless of their background or identity.